Detalhe da pesquisa
1.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med
; 387(12): 1089-1098, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027570
2.
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 146(16): 1210-1224, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029465
3.
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
Eur Heart J
; 43(41): 4406-4417, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029309
4.
Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project.
Cardiovasc Diabetol
; 21(1): 125, 2022 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780152
5.
Monitoring of cerebral oximetry in patients with postural orthostatic tachycardia syndrome.
Europace
; 21(10): 1575-1583, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384930
6.
N-Terminal Prosomatostatin and Risk of Vascular Dementia.
Cerebrovasc Dis
; 44(5-6): 259-265, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28854435
7.
Longitudinal and postural changes of blood pressure predict dementia: the Malmö Preventive Project.
Eur J Epidemiol
; 32(4): 327-336, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28190139
8.
The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study.
Scand J Clin Lab Invest
; 76(7): 568-574, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622713
9.
Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER data.
Eur J Heart Fail
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509642
10.
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER.
JACC Heart Fail
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573262
11.
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction.
JAMA Cardiol
; 9(5): 457-465, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536153
12.
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
Eur J Heart Fail
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700986
13.
Galectin-4 is associated with diabetes and obesity in a heart failure population.
Sci Rep
; 13(1): 20285, 2023 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37985679
14.
The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health-economic analysis of the DELIVER trial.
Eur J Heart Fail
; 25(8): 1386-1395, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344985
15.
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER.
Eur J Heart Fail
; 25(11): 2078-2090, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634087
16.
Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
J Am Coll Cardiol
; 82(10): 1014-1026, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37610398
17.
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER.
Circ Heart Fail
; 16(12): e010898, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886880
18.
Physical Inactivity Is Associated With Post-discharge Mortality and Re-hospitalization Risk Among Swedish Heart Failure Patients-The HARVEST-Malmö Study.
Front Cardiovasc Med
; 9: 843029, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35265689
19.
The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation-The HARVEST-Malmö study.
Front Cardiovasc Med
; 9: 982871, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36337899
20.
Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: Shrunken pore syndrome and proteomic associations.
Proteomics Clin Appl
; 15(4): e2000089, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682349